ADMA Biologics
Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ADMA
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center.
ADMA Key Statistics
Stock Snapshot
The current ADMA Biologics(ADMA) stock price is $8.34, with a market capitalization of 1.93B. The stock trades at a price-to-earnings (P/E) ratio of 12.49.
On 2026-05-08, ADMA Biologics(ADMA) stock traded between a low of $8.34 and a high of $8.92. Shares are currently priced at $8.34, which is +0.1% above the low and -6.5% below the high.
The ADMA Biologics(ADMA)'s current trading volume is 2.74M, compared to an average daily volume of 8.63M.
During the past year, ADMA Biologics(ADMA) stock moved between $7.21 at its lowest and $22.73 at its peak.
During the past year, ADMA Biologics(ADMA) stock moved between $7.21 at its lowest and $22.73 at its peak.
ADMA News
ADMA Biologics Inc ((ADMA)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and...
FDA approves an expanded label for ASCENIV to include pediatric immunodeficiency patients aged two and older. The decision allows earlier intervention for immu...
Sees FY26 adjusted EBITDA $265M-$300M. Grossman continued, “We believe the first quarter results likely represent a trough revenue baseline driven by what we an...
More ADMA News
Image source: The Motley Fool. Wednesday, May 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Adam S. Grossman Chief Financia...
Andrew Sather: Why Some Stock Buybacks Are Basically “Putting Money on Fire” By Omor Ibne Ehsan Published May 4, 10:57AM EDT Quick Read ADMA Biologics (ADMA)...
Adma Biologics (ADMA) announced the FDA has approved the company’s supplemental biologics license application submitted under section 351 of the Public Health S...
Culper Research’s recent report accusing ADMA Biologics (ADMA) of inflating reported growth through its distribution practices, along with the subsequent Pomera...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.